By: Frank Angst Three years after the deaths of horses in Kentucky and Florida were linked to a Lexington compounding pharmacy, the Kentucky Board of Pharmacy strengthened its regulation of the industry in a move it hopes will protect animal—and human—lives. It's a change many see as a needed step forward in terms of safety, and several
By: Natalie Voss From Dec. 28 to Dec 30, 2015, inspectors from Florida's Department of Health observed business at Ergogenic Labs in Wellington, Fla., where pharmacist Scott Mangini oversaw the compounding of human and animal drugs. The inspectors were not happy with what they found. In a subsequent report dated Jan. 5, 2016, they “noted
By: Press Release Abbott's Compounding Pharmacy is voluntarily recalling all unexpired lots of sterile compounded products due to concerns of lack of sterility assurance. All unexpired lots are subject to the recall. These include injectable medications, sterile solutions, eye drops, and eye ointments. All recalled products were distributed to patients, physician offices and clinics, and
By: Pat Raia The World Health Organization (WHO) has opposed a Chinese United Nations (U.N.) delegation request of the U.N. Commission on Narcotic Drugs to place a commonly used anesthetic and analgesic, ketamine, under international control. The Chinese delegation made its request—which would restrict veterinarians’ ability to access it—in March 2015 on grounds that ketamine
by Press Release Cox Veterinary Laboratory, Inc. is voluntarily recalling the lots of Gastroade Xtra identified below down to the consumer level distributed nationwide. Gastroade Xtra was previously marketed by Cox Veterinary Laboratory as an OTC drug for use in horses, and contains Omeprazole. This recall has been initiated due to information from the FDA
by Paulick Report Staff Dr. Mary Scollay, Dr. Rick Arthur, and Dr. Lynn Hovda submitted the following letter to the Paulick Report voicing their support of the RCI’s recent decision to establish rules on compounded medications in horse racing: The Association of Racing Commissioners International (RCI) recently announced they have given approval to a Model
NEWS RELEASE April 24, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD NAMES INTERIM EXECUTIVE DIRECTOR, RECEIVES UPDATES ON DRUG ADMINISTRATION STUDIES AND MAKES THRESHOLD LEVEL RECOMMENDATION At its April 23 meeting in Dallas, Texas, the Racing Medication and Testing Consortium (RMTC) board of directors approved an agreement with The Jockey Club to engage the
NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
